Clinical Trial Update: A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) [Phase 2]

View source ↗

Summary

Phase 2 study ARIEL2 evaluating rucaparib in platinum-sensitive relapsed high-grade ovarian/fallopian tube/primary peritoneal cancer completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Rucaparib (rucaparib)

Snippet

Sponsor: pharmaand GmbH | Conditions: Ovarian Cancer, Epithelial Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-07-13